Rubin P, Blaschke T
Br J Clin Pharmacol. 1980 Feb;9(2):177-82. doi: 10.1111/j.1365-2125.1980.tb05830.x.
Experiments have been performed using equilibrium dialysis to determine the binding of [C]-prazosin to albumin, to α-acid glycoprotein and to the plasma proteins of normal subjects and of patients with cirrhosis, chronic renal failure or chronic heart failure. The influence of propranolol on prazosin binding has been studied. In addition, red blood cell to plasma partitioning of prazosin has been quantified. The dissociation constant for prazosin binding to albumin was 3 × 10 M and to α-acid glycoprotein was 1.9 × 10 M. In fourteen normal subjects the free fraction of prazosin was 0.051 ± 0.007. In seven patients with cirrhosis free fraction of prazosin was 0.064 ± 0.017 ( < 0.05 compared to normal). In nine patients with chronic renal failure the free fraction was 0.077 ± 0.033 ( < 0.05) and in eight congestive heart failure patients the value was 0.064 ± 0.027 ( > 0.05). The range of prazosin free fraction was substantially greater in the patients than in normal subjects. In cirrhotic patients free fraction of prazosin correlated significantly ( = -0.92) with albumin concentration. Propranolol did not influence prazosin protein binding. In blood 20% of prazosin is associated with red cells. The considerably greater range of prazosin free fraction in the patients suggests that caution should be used when prescribing the drug for subjects with these conditions. Both albumin and the acute phase reactant α-acid glycoprotein bind prazosin
已进行实验,采用平衡透析法测定[C] - 哌唑嗪与白蛋白、α - 酸性糖蛋白以及正常受试者和肝硬化、慢性肾衰竭或慢性心力衰竭患者血浆蛋白的结合情况。研究了普萘洛尔对哌唑嗪结合的影响。此外,还对哌唑嗪在红细胞与血浆之间的分配进行了定量分析。哌唑嗪与白蛋白结合的解离常数为3×10⁻⁶M,与α - 酸性糖蛋白结合的解离常数为1.9×10⁻⁶M。在14名正常受试者中,哌唑嗪的游离分数为0.051±0.007。7名肝硬化患者中哌唑嗪的游离分数为0.064±0.017(与正常相比P<0.05)。9名慢性肾衰竭患者的游离分数为0.077±0.033(P<0.05),8名充血性心力衰竭患者的该值为0.064±0.027(P>0.05)。患者中哌唑嗪游离分数的范围明显大于正常受试者。在肝硬化患者中,哌唑嗪的游离分数与白蛋白浓度显著相关(r = -0.92)。普萘洛尔不影响哌唑嗪与蛋白质的结合。在血液中,20%的哌唑嗪与红细胞结合。患者中哌唑嗪游离分数范围明显更大,这表明在为这些疾病患者开此药时应谨慎。白蛋白和急性期反应物α - 酸性糖蛋白均可结合哌唑嗪